Table 2A. Predictors of targeted therapy receipt in cM1 patients, multivariable logistic regression analysis.

	OR	95% CI for OR		p-Value
		Lower	Higher
Age at Diagnosis	0.97	0.96	0.97	<0.01
Sex
Male	Reference
Female	0.95	0.85	1.06	0.37
Race
Non-Hispanic White	Reference
Hispanic	1	0.86	1.17	0.99
Native American	2.18	1.31	3.62	<0.01
Asian or Pacific Islander	1.2	0.96	1.5	0.11
Non-Hispanic Black	0.81	0.68	0.97	0.02
Socioeconomic Status
First Quartile (highest)	Reference
Second Quartile	0.85	0.72	1	0.04
Third Quartile	0.84	0.72	0.98	0.03
Fourth Quartile (lowest)	0.78	0.66	0.91	<0.01
Insurance
Insured	Reference
Medicaid	0.79	0.68	0.92	<0.01
Uninsured	0.69	0.54	0.88	<0.01
Region
Northeast	Reference
Southeast	1.08	0.89	1.3	0.43
Midwest	1.18	0.98	1.42	0.07
West	0.98	0.83	1.16	0.84
Marital Status
Married	Reference
Single	0.63	0.55	0.73	<0.01
Divorced/Separated	0.97	0.83	1.13	0.66
Widowed	0.71	0.59	0.84	<0.01
Laterality
Bilateral primary	Reference
Left-sided primary	1.11	0.55	2.25	0.77
Right-sided primary	1.12	0.55	2.27	0.75
cT stage
cT1	Reference
cT2	1.28	1.1	1.49	<0.01
cT3	1.28	1.12	1.47	<0.01
cT4	1.4	1.18	1.66	<0.01
cN stage
cN0	Reference
cN1	1.46	1.31	1.62	<0.01
Histology
Clear cell RCC	Reference
Papillary RCC	0.88	0.69	1.12	0.31
Chromophobe RCC	0.76	0.45	1.3	0.32
Sarcomatoid RCC	0.93	0.75	1.15	0.48
Surgical Intervention
No Surgery	Reference
Partial Nephrectomy	0.4	0.28	0.59	<0.01
Radical Nephrectomy	0.73	0.65	0.83	<0.01